Different niches for stem cells carrying the same oncogenic driver affect pathogenesis and therapy response in myeloproliferative neoplasms.

Autor: Grockowiak E; National Health Service Blood and Transplant, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK., Korn C; National Health Service Blood and Transplant, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK., Rak J; National Health Service Blood and Transplant, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK., Lysenko V; Department of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland., Hallou A; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.; Wellcome Trust-CRUK Gurdon Institute, University of Cambridge, Cambridge, UK.; Cavendish Laboratory, Department of Physics, University of Cambridge, Cambridge, UK.; Department of Applied Mathematics and Theoretical Physics, Centre for Mathematical Sciences, University of Cambridge, Cambridge, UK., Panvini FM; National Health Service Blood and Transplant, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK., Williams M; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK., Fielding C; National Health Service Blood and Transplant, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK., Fang Z; National Health Service Blood and Transplant, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK., Khatib-Massalha E; National Health Service Blood and Transplant, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK., García-García A; National Health Service Blood and Transplant, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK., Li J; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK., Khorshed RA; Department of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London, UK.; The Sir Francis Crick Institute, London, UK., González-Antón S; Department of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London, UK.; The Sir Francis Crick Institute, London, UK., Baxter EJ; National Health Service Blood and Transplant, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Kusumbe A; The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK., Wilkins BS; Guy's and Saint Thomas' NHS Foundation Trust, London, UK., Green A; Guy's and Saint Thomas' NHS Foundation Trust, London, UK., Simons BD; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.; Wellcome Trust-CRUK Gurdon Institute, University of Cambridge, Cambridge, UK.; Cavendish Laboratory, Department of Physics, University of Cambridge, Cambridge, UK.; Department of Applied Mathematics and Theoretical Physics, Centre for Mathematical Sciences, University of Cambridge, Cambridge, UK., Harrison CN; Guy's and Saint Thomas' NHS Foundation Trust, London, UK., Green AR; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK., Lo Celso C; Department of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London, UK.; The Sir Francis Crick Institute, London, UK., Theocharides APA; Department of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland., Méndez-Ferrer S; National Health Service Blood and Transplant, Cambridge, UK. sm2116@cam.ac.uk.; Department of Haematology, University of Cambridge, Cambridge, UK. sm2116@cam.ac.uk.; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK. sm2116@cam.ac.uk.

Publikováno v: Nature cancer [Nat Cancer] 2023 Aug; Vol. 4 (8), pp. 1193-1209. Date of Electronic Publication: 2023 Aug 07.

Multicolor Immunofluorescence Staining of Paraffin-Embedded Human Bone Marrow Sections.

Autor: Panvini FM; Institute of Life Sciences, Sant'Anna School of Advanced Studies, Pisa, Italy., Pacini S; Department of Clinical and Experimental Medicine, Hematology Division, University of Pisa, Pisa, Italy., Mazzoni S; Department of Translational Research and New Technology in Medicine, University of Pisa, Pisa, Italy., Méndez-Ferrer S; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK. sm2116@cam.ac.uk.; Department of Haematology, University of Cambridge, Cambridge, UK. sm2116@cam.ac.uk.; National Health Service Blood and Transplant, Cambridge, UK. sm2116@cam.ac.uk.

Publikováno v: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2021; Vol. 2308, pp. 119-126.

Mesangiogenic Progenitor Cells and musculoskeletal tissue regeneration: differences between adipose-derived and bone marrow-derived cells?

Autor: Barachini S; Hematology Division, Dept. Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Pacini S; Hematology Division, Dept. Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Montali M; Hematology Division, Dept. Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Panvini FM; Hematology Division, Dept. Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Carnicelli V; Dept. Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy., Piolanti N; First Orthopedic Division University of Pisa, Italy., Bonicoli E; First Orthopedic Division University of Pisa, Italy., Scaglione M; First Orthopedic Division University of Pisa, Italy., Parchi PD; First Orthopedic Division University of Pisa, Italy.

Publikováno v: Journal of biological regulators and homeostatic agents [J Biol Regul Homeost Agents] 2020 Sep-Oct; Vol. 34 (5 Suppl. 1), pp. 33-38. IORS Special Issue on Orthopedics.

Human adult mesangiogenic progenitor cells reveal an early angiogenic potential, which is lost after mesengenic differentiation.

Autor: Montali M; Department of Clinical and Experimental Medicine, Hematology Division, University of Pisa, Via Roma 56, 56126, Pisa, Italy., Panvini FM; Department of Clinical and Experimental Medicine, Hematology Division, University of Pisa, Via Roma 56, 56126, Pisa, Italy., Barachini S; Department of Clinical and Experimental Medicine, Hematology Division, University of Pisa, Via Roma 56, 56126, Pisa, Italy., Ronca F; Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy., Carnicelli V; Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy., Mazzoni S; Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy., Petrini I; Department of Translational Research and New Technology in Medicine, University of Pisa, Pisa, Italy., Pacini S; Department of Clinical and Experimental Medicine, Hematology Division, University of Pisa, Via Roma 56, 56126, Pisa, Italy. simone.pacini@do.unipi.it.

Publikováno v: Stem cell research & therapy [Stem Cell Res Ther] 2017 May 02; Vol. 8 (1), pp. 106. Date of Electronic Publication: 2017 May 02.

Growth Factor Content in Human Sera Affects the Isolation of Mesangiogenic Progenitor Cells (MPCs) from Human Bone Marrow.

Autor: Montali M; Department of Clinical and Experimental Medicine, University of Pisa Pisa, Italy., Barachini S; Department of Clinical and Experimental Medicine, University of Pisa Pisa, Italy., Panvini FM; Department of Clinical and Experimental Medicine, University of Pisa Pisa, Italy., Carnicelli V; Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa Pisa, Italy., Fulceri F; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa Pisa, Italy., Petrini I; Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa Pisa, Italy., Pacini S; Department of Clinical and Experimental Medicine, University of Pisa Pisa, Italy.

Publikováno v: Frontiers in cell and developmental biology [Front Cell Dev Biol] 2016 Oct 17; Vol. 4, pp. 114. Date of Electronic Publication: 2016 Oct 17 (Print Publication: 2016).